Cargando…

A transgenic mouse model for tumour immunotherapy: induction of an anti-idiotype response to human MUC1

MUC1 is a membrane bound, polymorphic epithelial mucin expressed at the luminal surface of glandular epithelium. It is highly expressed in an underglycosylated form on carcinomas and metastatic lesions and is, therefore, a potential target for immunotherapy of cancer. The monoclonal antibody HMFG1 b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilkinson, R W, Ross, E L, Lee-MacAry, A E, Laylor, R, Burchell, J, Taylor-Papadimitriou, J, Snary, D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363579/ https://www.ncbi.nlm.nih.gov/pubmed/11027434 http://dx.doi.org/10.1054/bjoc.2000.1431

Ejemplares similares

Latest developments in MUC1 immunotherapy
por: Taylor-Papadimitriou, Joyce, et al.
Publicado: (2018)

Development of breast cancer immunotherapy using MUC1 retargeted T lymphocytes
por: Wilkie, S, et al.
Publicado: (2006)

The Molecular Engineering of an Anti-Idiotypic Antibody for Pharmacokinetic Analysis of a Fully Human Anti-Infective
por: Lim, She Yah, et al.
Publicado: (2015)

Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes
por: Wilkie, S, et al.
Publicado: (2008)

Deregulation of idiotype expression. Induction of tolerance in an anti- idiotypic response
Publicado: (1982)

Induction of idiotype-bearing, nuclease-specific helper T cells by in vivo treatment with anti-idiotype
Publicado: (1981)

Alterations in Mucin Expression in Ovarian Mucinous Tumors: Immunohistochemical Analysis of MUC2, MUC5AC, MUC6, and CD10 Expression
por: Hirabayashi, Kenichi, et al.
Publicado: (2008)

Induction of antiphosphorylcholine antibody formation by anti-idiotypic antibodies
Publicado: (1975)

Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas
por: Picco, Gianfranco, et al.
Publicado: (2014)

The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers
por: Hamilton, J A, et al.
Publicado: (2000)

Induction of idiotype-specific suppressor T cells with antigen/antibody complexes
Publicado: (1983)

Idiotype-recognizing T helper cells that are not idiotype specific
Publicado: (1983)

Idiotypic regulation of the immune system. Common idiotypic specificities between idiotypes and antibodies raised against anti- idiotypic antibodies in rabbits
Publicado: (1979)

Idiotype-anti-idiotype network. II. Activation of silent clones by treatment at birth with idiotypes is associated with the expansion of idiotype-specific helper T cells
Publicado: (1982)

QUANTITATIVE INVESTIGATIONS OF IDIOTYPIC ANTIBODIES : III. PERSISTENCE AND VARIATIONS OF IDIOTYPIC SPECIFICITIES DURING THE COURSE OF IMMUNIZATION
por: MacDonald, A. Bruce, et al.
Publicado: (1970)

Induction of haem oxygenase-1 by nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth
por: Doi, K, et al.
Publicado: (1999)

Toward a fractalomic idiotype/anti-idiotypic paradigm
por: Chiappelli, Francesco, et al.
Publicado: (2022)

Induction of specific transplantation immune reactions using anti- idiotypic antibodies
Publicado: (1978)

Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells
por: Fredriksen, Agnete B., et al.
Publicado: (2012)

The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL
por: Beatson, Richard, et al.
Publicado: (2015)

Suppression of idiotype and generation of suppressor T cells with idiotype-conjugated thymocytes
Publicado: (1979)

MUC1 modulates the tumor immune microenvironment through the engagement of Siglec-9
por: Beatson, Richard, et al.
Publicado: (2016)

Induction of Fos protein expression in spinal cord neurons of tumour-bearing rats
por: Kergozien, S, et al.
Publicado: (1999)

MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer
por: Matull, W R, et al.
Publicado: (2008)

Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer
por: Maxwell-Armstrong, C A, et al.
Publicado: (2001)

QUANTITATIVE INVESTIGATIONS OF IDIOTYPIC ANTIBODIES : II. NONPRECIPITATING ANTIBODIES
por: Hopper, John E., et al.
Publicado: (1970)

Cancer-associated autoantibodies to MUC1 and MUC4—A blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screening
por: Pedersen, Johannes W, et al.
Publicado: (2014)

Induction of delayed-type hypersensitivity to azobenzenearsonate by a monoclonal anti-idiotype antibody
Publicado: (1981)

Mechanisms of idiotype suppression. I. In vitro generation of idiotype- specific suppressor T cells by anti-idiotype antibodies and specific antigen
Publicado: (1979)

Selective suppression of the major idiotypic component of an antihapten response by soluble T cell-derived factors with idiotypic or anti- idiotypic receptors
Publicado: (1980)

Modulation of MUC1 mucin as an escape mechanism of breast cancer cells from autologous cytotoxic T-lymphocytes
por: Kontani, K, et al.
Publicado: (2001)

Molecular Mimics of the Tumour Antigen MUC1
por: James, Tharappel C., et al.
Publicado: (2012)

Induction of matrix metalloprotease-1 gene expression by retinoic acid in the human pancreatic tumour cell line Dan-G
por: Marschall, Z von, et al.
Publicado: (1999)

Modification of T cell antinuclease idiotype expression by in vivo administration of anti-idiotype
Publicado: (1982)

Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2
por: Bizouarne, N, et al.
Publicado: (2001)

Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma
por: Matsumoto*, T, et al.
Publicado: (1999)

Modification of non-conservative double-strand break (DSB) rejoining activity after the induction of cisplatin resistance in human tumour cells
por: Britten, R A, et al.
Publicado: (1999)

Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis
por: Blixt, Ola, et al.
Publicado: (2011)

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice
por: Lakshminarayanan, Vani, et al.
Publicado: (2016)

Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity
por: Bennewith, K L, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_vv2dmdqkmb9fq1sbrrb1o85ucc